Institutional investors purchased a net $7.9 million shares of NVO during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 8.10% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.6 Million shares of Novo Nordisk A/S
LAZARD ASSET MANAGEMENT LLC Bought 1.2 Million shares of Novo Nordisk A/S
NORTHERN TRUST INVESTMENTS, INC. Bought 792.6 Thousand shares of Novo Nordisk A/S